End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
259,500 KRW | +1.76% | -5.98% | +163.45% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+163.45% | 9.81B | |
+1.43% | 94.45B | |
-1.71% | 38.9B | |
-12.95% | 32.56B | |
-12.43% | 15.98B | |
-1.88% | 13.82B | |
-12.63% | 11.34B | |
-53.23% | 9.67B | |
+3.52% | 8.91B | |
+6.17% | 7.97B |
- Stock Market
- Equities
- A196170 Stock
- News ALTEOGEN Inc.
- ALTEOGEN Inc. announced that it has received KRW 74.999925 billion in funding from SG Core Co., Ltd.